ATE367797T1 - Verwendundung von rhamnolipiden als kosmetika - Google Patents

Verwendundung von rhamnolipiden als kosmetika

Info

Publication number
ATE367797T1
ATE367797T1 AT99936031T AT99936031T ATE367797T1 AT E367797 T1 ATE367797 T1 AT E367797T1 AT 99936031 T AT99936031 T AT 99936031T AT 99936031 T AT99936031 T AT 99936031T AT E367797 T1 ATE367797 T1 AT E367797T1
Authority
AT
Austria
Prior art keywords
treatment
rhamnolipids
prevention
cosmetics
schizophrenia
Prior art date
Application number
AT99936031T
Other languages
English (en)
Inventor
Tatjana Piljac
Goran Piljac
Original Assignee
Paradigm Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paradigm Biomedical Inc filed Critical Paradigm Biomedical Inc
Application granted granted Critical
Publication of ATE367797T1 publication Critical patent/ATE367797T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99936031T 1998-02-24 1999-02-24 Verwendundung von rhamnolipiden als kosmetika ATE367797T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7595998P 1998-02-24 1998-02-24

Publications (1)

Publication Number Publication Date
ATE367797T1 true ATE367797T1 (de) 2007-08-15

Family

ID=22129018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936031T ATE367797T1 (de) 1998-02-24 1999-02-24 Verwendundung von rhamnolipiden als kosmetika

Country Status (10)

Country Link
US (2) US20070155678A1 (de)
EP (1) EP1056462B1 (de)
JP (2) JP2002504513A (de)
AT (1) ATE367797T1 (de)
AU (1) AU747088B2 (de)
CA (1) CA2321926C (de)
DE (1) DE69936635T2 (de)
DK (1) DK1056462T3 (de)
ES (1) ES2291036T3 (de)
WO (1) WO1999043334A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200100B1 (de) * 1999-08-05 2010-07-14 Paradigm Biomedical Inc. Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
EP2046930A4 (de) * 2006-07-27 2012-06-27 Aurora Advance Beauty Labs Auf rhamnolipid basierende formulierungen
EP2074889A4 (de) * 2006-10-17 2013-10-30 Idemitsu Kosan Co Tierfutteradditiv und tierfutter
JO3416B1 (ar) 2009-04-27 2019-10-20 Jeneil Biosurfactant Co Llc تركيبات مضادة للبكتيريا وطرق استخدامها
DK2648809T3 (da) 2010-12-09 2019-07-15 Y&B Mothers Choice Ltd Naturlige formuleringer
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
KR20140019307A (ko) 2010-12-09 2014-02-14 와이앤드비 마더스 초이스 엘티디. 사포닌을 포함하는 제형 및 이의 용도
WO2012177593A2 (en) 2011-06-21 2012-12-27 Rhamnopharma Inc. Method for treating obesity
MY197977A (en) 2013-03-15 2023-07-25 Jeneil Biosurfactant Co Llc Antimicrobial compositions and related methods of use
WO2014173659A1 (en) 2013-04-25 2014-10-30 Unilever Plc Cleansing compositions with improved dispensing and suspension properties
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
CN105326848A (zh) * 2015-11-26 2016-02-17 浙江大学 一种鼠李糖脂在制备抗纤维化药物制剂中的用途
BR102017000578B1 (pt) 2017-01-11 2019-04-02 Natura Cosméticos S.A. Processo de obtenção de ramnolipídeo produzido por pseudomonas ou enterobacter utilizando o resíduo de semente de andiroba ou murumuru
EP3980022B1 (de) 2019-06-07 2025-01-15 Dale Biotech, LLC Behandlung der dupuytren'schen krankheit, der arthrose oder der adhäsiven kapsulitis mit rhamnolipiden.
US12063928B2 (en) 2020-01-31 2024-08-20 Jeneil Biosurfactant Company, Llc Antimicrobial compositions for modulation of fruit and vegetable tissue necrosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3405664A1 (de) * 1984-02-17 1985-09-05 Wintershall Ag, 3100 Celle Verfahren zur biotechnischen herstellung von rhamnolipiden und rhamnolipide mit nur einem ss-hydroxidecancarbonsaeurerest im molekuel
JPS63182029A (ja) * 1987-01-22 1988-07-27 Agency Of Ind Science & Technol リポソ−ム
US4933281A (en) * 1987-03-17 1990-06-12 The University Of Iowa Research Foundation Method for producing rhamnose
JPS63253025A (ja) * 1987-04-09 1988-10-20 Yamanouchi Pharmaceut Co Ltd ホスホリパ−ゼａ↓２阻害剤
EP0288965A2 (de) * 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung
DE4030262A1 (de) * 1990-09-25 1992-03-26 Suedzucker Ag Verfahren zur herstellung von rhamnose aus rhamnolipiden
BE1005704A4 (nl) * 1992-02-04 1993-12-21 Piljac Goran & Piljac Visnja Farmaceutisch preparaat op basis van rhamnolipide.
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
US5455232A (en) * 1992-02-04 1995-10-03 Piljac; Goran Pharmaceutical preparation based on rhamnolipid

Also Published As

Publication number Publication date
CA2321926C (en) 2010-04-27
US20070155678A1 (en) 2007-07-05
DE69936635T2 (de) 2008-05-08
EP1056462A1 (de) 2000-12-06
DE69936635D1 (de) 2007-09-06
JP2011001373A (ja) 2011-01-06
EP1056462A4 (de) 2004-12-01
DK1056462T3 (da) 2007-12-03
AU747088B2 (en) 2002-05-09
WO1999043334A1 (en) 1999-09-02
ES2291036T3 (es) 2008-02-16
EP1056462B1 (de) 2007-07-25
US20090220603A1 (en) 2009-09-03
AU3304899A (en) 1999-09-15
JP2002504513A (ja) 2002-02-12
CA2321926A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
DE69936635D1 (de) Verwendundung von Rhamnolipiden als Kosmetika
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
ES2151921T3 (es) Analogo de dolastatina.
BR9801652A (pt) Resorcinil-triazinas
TR28139A (tr) Polisilokzan graftli polimer ihtive eden yapistirici madde ve bunu iceren kozmetik terkipleri.
DE60031387D1 (de) Wässrige zusammensetzungen auf basis von polyamidsäure
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
CA2306040A1 (en) Coloring agent-containing sunless tanning compositions
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
FR2719768B1 (fr) Utilisation d'extraits de bactéries filamenteuses comme agents cosmétiques contre le vieillissement cutané.
MX9303594A (es) Oximas piridino, pirrolidino y azepino substituidas utiles como agentes antiateroscleroticos y antihipercolesterolemicos.
PT615751E (pt) Utilizacao de antagonistas de taquinina no tratamento da emese
DE50007791D1 (de) Parfümkomposition mit duftsequenz
DE69925705D1 (de) Nanokapseln auf basis von poly(alkylène adipate),ihren Verfahren, und diese enthaltende kosmetische oder dermatologische Zusammensetzungen
PT766557E (pt) Composicoes de aplicacao topica compreendendo n-acetil-cisteina
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
DE60044674D1 (de) Verwendung von rhamnolipiden zur wundheilung, behaund periodontaler regeneration
FR2748937B1 (fr) Utilisation d'alpha-alklyglucosides et d'esters d'alpha-alkylglucosides en tant qu'agents emulsionnants anti-microbiens
BR0207654A (pt) Composição que compreende um creme ou loção base
PL356332A1 (pl) Kompozycja rozjaśniająca i farbująca włosy mającapH większe niż 10, zawierająca cholesterol
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
NO980296L (no) Forbedrede terapeutiske midler
EP0826764A3 (de) Verwendung substituierter 2-Acetylbenzofurane als Riechstoffe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties